India  

Pfizer and AstraZeneca vaccines 'highly effective' at preventing hospital admissions in over-80s

Sky News Wednesday, 3 March 2021
Pfizer and AstraZeneca vaccines 'highly effective' at preventing hospital admissions in over-80sThe Pfizer-BioNTech and Oxford-AstraZeneca coronavirus vaccines are both highly effective at preventing over-80s from being admitted to hospital, according to a new study.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Pfizer Pfizer American multinational pharmaceutical corporation

EU to get an extra 50 million COVID vaccines by the end of June [Video]

EU to get an extra 50 million COVID vaccines by the end of June

The European Commission chief said the total doses EU countries will receive from Pfizer will now be 250 million in the second quarter of this year.

Credit: Euronews English    Duration: 02:07Published
Pfizer CEO: New vaccine shot in 6-12 months may be needed | Oneindia News [Video]

Pfizer CEO: New vaccine shot in 6-12 months may be needed | Oneindia News

Pfizer CEO Albert Bourla has sparked a whirldwind of discussions and memes on social media after he said that people would need a third dose of the Pfizer vaccine perhaps within 6 to 12 months of vaccination. #PfizerCEO #CovidVaccine #AlbertBourla

Credit: Oneindia    Duration: 01:33Published
U.S. preparing for COVID-19 booster within a year [Video]

U.S. preparing for COVID-19 booster within a year

The United States is preparing for the possibility that a booster shot will be needed between nine to 12 months after people are initially vaccinated against COVID-19, a White House official said on Thursday. Jayson Albano reports.

Credit: Reuters - Politics    Duration: 01:23Published
Pfizer CEO says people 'likely' will need third COVID shot in next 12 months [Video]

Pfizer CEO says people 'likely' will need third COVID shot in next 12 months

Pfizer CEO Albert Bourla said that people would likely need a third shot of the Pfizer/BioNTech COVID-19 vaccine within 12 months after being fully vaccinated.

Credit: ABC Action News    Duration: 02:18Published

Covid-19: India shifts from mass vaccine exporter to importer, worrying the world

Facing soaring cases and overflowing hospitals after lockdown restrictions were eased, India abruptly changed the rules to allow it to fast-track vaccine..
IndiaTimes

AstraZeneca British-Swedish pharmaceutical company

Fauci believes J&J vaccine will 'get back on track' [Video]

Fauci believes J&J vaccine will 'get back on track'

Anthony Fauci, the top U.S. infectious disease doctor, hopes U.S. regulators will make a quick decision to lift a pause on the Johnson & Johnson vaccine and get that vaccine "back on track," he said in an interview with Reuters on Thursday. Gloria Tso reports.

Credit: Reuters - Politics    Duration: 02:19Published
Norway should stop using the AstraZeneca vaccine, says country's public health institute [Video]

Norway should stop using the AstraZeneca vaccine, says country's public health institute

It comes a day after Denmark became the first country in Europe to abandon the jab over links with very rare blood clots.

Credit: Euronews English    Duration: 02:49Published
European countries express interest in purchasing Denmark's AstraZeneca vaccines [Video]

European countries express interest in purchasing Denmark's AstraZeneca vaccines

The World Health Organization said that Denmark was considering sharing unused vaccine doses with poorer countries.

Credit: euronews (in English)    Duration: 02:11Published

University of Oxford University of Oxford Collegiate research university in Oxford, England

Risk of blood clot after COVID is eight times higher than after AstraZeneca jab - study

The risk of developing a blood clot after having COVID-19 is eight times higher than after being given the Oxford-AstraZeneca vaccine, according to a study by..
Sky News
Oxford Vaccine Group on AZ jab [Video]

Oxford Vaccine Group on AZ jab

The developers of the Oxford-AstraZeneca jab give their reaction to the latest regulatory advice on their vaccine. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:47Published
Blood clot victim’s sister speaks [Video]

Blood clot victim’s sister speaks

The sister of a 59-year-old man who died of blood clots, possibly related to the Oxford-AstraZeneca vaccine, insists everyone should still take the AZ jab for the good of the population. Neil Astles died on Sunday and is the UK’s first named blood clot victim. Alison Astles said her brother is “extraordinarily unlucky”. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:02Published
People under 30 to be offered alternative Covid vaccine to AstraZeneca jab [Video]

People under 30 to be offered alternative Covid vaccine to AstraZeneca jab

People under the age of 30 are to be offered an alternative Covid vaccine to the Oxford-AstraZeneca jab.

Credit: Cover Video STUDIO    Duration: 01:03Published
Sturgeon: I would take AZ jab ‘without hesitation’ [Video]

Sturgeon: I would take AZ jab ‘without hesitation’

First Minister Nicola Sturgeon has said she would take the Oxford-AstraZeneca vaccine "without hesitation", as she seeks to allay concerns over a very rare risk of blood clots. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:44Published

Related videos from verified sources

EU Commission May Not Be Renewing Vaccine Contracts With AstraZeneca and Johnson & Johnson [Video]

EU Commission May Not Be Renewing Vaccine Contracts With AstraZeneca and Johnson & Johnson

EU Commission May Not Be Renewing Vaccine Contracts With, AstraZeneca and Johnson & Johnson. The EU Commission has reportedly decided to move away from AstraZeneca and Johnson & Johnson’s..

Credit: Wibbitz Top Stories     Duration: 01:15Published
Daily Covid-19 Minute: Pfizer’s Six-Month Data [Video]

Daily Covid-19 Minute: Pfizer’s Six-Month Data

Pfizer has revealed six-month follow-up data from their covid vaccine trial. They confirmed protection from their vaccine lasts for at least six months after the second dose. Prior to this, the only..

Credit: CBS 62 Detroit     Duration: 00:56Published
Children's Hospital part of Pfizer vaccine trial for patients more than 6 months old [Video]

Children's Hospital part of Pfizer vaccine trial for patients more than 6 months old

A recent clinical trial found that the Pfizer vaccine is possibly 100 percent effective in children 12 to 15-years-old. And while more review and approval are needed before that age group is vaccinated..

Credit: KMTV Action 3 News     Duration: 02:21Published

Related news from verified sources

AstraZeneca effective against Brazil variant, reveals Oxford study

Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1,...
Zee News Also reported by •HindunewKerala.com